← back to search

Hongtao Diao

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Downregulation and upregulation, Medicine, Cardiac fibrosis, Fibrosis, Gene knockdown, and Cardiac function curve.
h-index
citations
538
works
18
NIH funding
primary concept
email

Recent publications

Zinc finger BED-type containing 6 (ZBED6) ameliorates cardiac fibrosis by inhibiting Piezo1 transcription and YAP nuclear translocation
Acta Pharmacologica Sinica 2026cited by 2position: middledoi
A novel deacetylase inhibitor KLX suppresses liver fibrosis by deacetylating PPARγ through promoting ubiquitination-mediated HDAC1 degradation
Science China Life Sciences 2025cited by 6position: middledoi
KLX ameliorates liver cancer progression by mediating ZBP1 transcription and ubiquitination and increasing ZBP1-induced PANoptosis
Acta Pharmacologica Sinica 2025cited by 5position: middledoi
Organelle interplay in cardiovascular diseases: Mechanisms, pathogenesis, and therapeutic perspectives
Biomedicine & Pharmacotherapy 2025cited by 3position: middledoi
YTHDF3-mediated FLCN/cPLA2 axis improves cardiac fibrosis via suppressing lysosomal function
Acta Pharmacologica Sinica 2025cited by 2position: middledoi
Circular RNA circDhx32 promotes cardiac inflammatory responses in mouse cardiac ischemia-reperfusion injury via binding to FOXO1 competed with AdipoR1
Acta Pharmacologica Sinica 2025cited by 2position: middledoi
Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
British Journal of Pharmacology 2024cited by 9position: middledoi
Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques
Journal of Ethnopharmacology 2024cited by 6position: middledoi
m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translation
Frontiers of Medicine 2024cited by 6position: middledoi
YTHDF2 Promotes Cardiac Ferroptosis <i>via</i> Degradation of SLC7A11 in Cardiac Ischemia–Reperfusion Injury
Antioxidants and Redox Signaling 2023cited by 27position: middledoi
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice
Biomedicine & Pharmacotherapy 2023cited by 21position: middledoi
Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA
Journal of Ethnopharmacology 2023cited by 19position: middledoi
Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice
Cell Death Discovery 2022cited by 241position: middledoi
MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2
Pharmacological Research 2022cited by 52position: middledoi
The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway
Journal of Ethnopharmacology 2022cited by 33position: firstdoi
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation
Biomedicine & Pharmacotherapy 2022cited by 32position: middledoi
FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway
Biomedicine & Pharmacotherapy 2022cited by 17position: middledoi
LncRNA MIAT impairs cardiac contractile function by acting on mitochondrial translocator protein TSPO in a mouse model of myocardial infarction
Signal Transduction and Targeted Therapy 2021cited by 24position: middledoi
Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3
Acta Pharmaceutica Sinica B 2019cited by 59position: middledoi
MicroRNA‑1 downregulation induced by carvedilol protects cardiomyocytes against apoptosis by targeting heat shock protein 60
Molecular Medicine Reports 2019cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaoqi Shao · Guangzhou University of Chinese Medicine9 papers (2022–2025)Jiao Guo · Guangzhou University of Chinese Medicine8 papers (2022–2024)Meiling Yan · Fudan University7 papers (2022–2024)Weitao Jiang · Harbin Medical University7 papers (2023–2026)Xianglu Rong · Guangzhou University of Chinese Medicine7 papers (2022–2023)Baofeng Yang · Shenyang Pharmaceutical University6 papers (2019–2025)Lexun Wang · Guangdong Pharmaceutical University4 papers (2022–2024)Jinglun Song · Harbin Medical University4 papers (2023–2025)Yüting Xiong · Harbin Medical University4 papers (2023–2025)Yu Bian · Harbin Medical University4 papers (2023–2026)Zhuo Wang · Harbin Medical University4 papers (2024–2025)Yu Bian · Ministry of Education of the People's Republic of China4 papers (2024–2025)Dongwei Wang · Guangzhou University of Chinese Medicine4 papers (2022–2024)Han Wu · Harbin Medical University4 papers (2024–2025)Ling-Hua Zeng · Harbin Medical University4 papers (2023–2025)Fangyin Yao · Harbin Medical University4 papers (2025–2026)Jiaming Ju · Harbin Medical University4 papers (2023–2025)Ping Pang · Harbin Medical University3 papers (2023–2025)Wenru Zeng · Guangzhou University of Chinese Medicine3 papers (2022–2024)Si Wei · Kunming University of Science and Technology3 papers (2024–2025)